Scripscan:Opto Circuits India Ltd
cmp:84
Traded in:Nse-bse
Story:OCL has a promising growth potential. It has shown fantastic results. It is expanding and increasing its acquisitions. It has seven subsidiaries in all and has a large client base. It is making efforts to expand more and increase its client base in the coming future. It has a strong distribution network. Acquisition of companies has made its distribution network stronger.With the improvement in lifestyle of people, expenditure in medical care is increasing, showing good prospects for the medical sector companies. The Company is also putting up their own manufacturing facility in SEZ near Mysore. It has recently received approval from US Food and Drug Administration (US FDA) to market two of the company’s product in the country. The company’s subsidiary, Mediaid Inc, has received approval from the US FDA for marketing its vital sign monitoring products in the US. OCL has shown a good financial performance for the FY’08 and for the second quarter FY’09. The mid cap stock is an attractive investment, taking into consideration the expansion, acquisition and growth of the company. It is expected to have an annualized EPS of around Rs 15.8 per share for FY09. At CMP of Rs 84, it trades at a P/E of just 5.4.Altogether a great buy.
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
